Catalyst Pharmaceuticals Insider Sold Shares Worth $1,740,200, According to a Recent SEC Filing-February 2024-www.financetom.com

Catalyst Pharmaceuticals Insider Sold Shares Worth $1,740,200, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Catalyst Pharmaceuticals Insider Sold Shares Worth $1,740,200, According to a Recent SEC Filing

Jun 3, 2025 2:24 PM

05:14 PM EDT, 06/03/2025 (MT Newswires) -- Richard J Daly, Director, President and CEO, on May 30, 2025, sold 70,000 shares in Catalyst Pharmaceuticals ( CPRX ) for $1,740,200. Following the Form 4 filing with the SEC, Daly has control over a total of 199,764 common shares of the company, with 199,764 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1369568/000116169725000179/xslF345X05/form4.xml

Previous page： Amazon says consumers cautious, forecasts revenue below Wall Street targets Next page： Cinemark's Q2 Earnings: Revenue And EPS Beat, CEO Highlights Record-Breaking 'Inside Out 2'

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Amazon says consumers cautious, forecasts revenue below Wall Street targets

Aug 2, 2024

(Corrects to paragraph 11 to say Amazon Web Services is Amazon's cloud business, not Microsoft's) By Greg Bensinger and Deborah Mary Sophia (Reuters) -Amazon.com reported slowing online sales growth in the second quarter and said cautious consumers were seeking out cheaper options for purchases, sending shares down nearly 8%. The after-hours stock drop came despite second-quarter profit and cloud computing...

Cinemark's Q2 Earnings: Revenue And EPS Beat, CEO Highlights Record-Breaking 'Inside Out 2'

Aug 2, 2024

Cinemark Holdings Inc ( CNK ) reported a fiscal second-quarter 2024 sales decline of 22.1% year-on-year to $734.2 million, beating the analyst consensus estimate of $691.6 million. EPS of $0.32 beat the analyst consensus estimate of $0.09. Admissions revenue decreased 23.5% to $365.8 million, and concession revenue declined 21.6% to $292.9 million, driven by a 22.4% decrease in attendance to 50.0 million patrons. Also Read:...

TELUS International Q2 Adjusted Earnings Flat, Revenue Down; 2024 Guidance Cut

Aug 2, 2024

09:23 AM EDT, 08/02/2024 (MT Newswires) -- TELUS International (TIXT) reported Q2 adjusted earnings Friday of $0.16 per diluted share, unchanged from a year earlier. Analysts polled by Capital IQ expected $0.26. Revenue for the quarter ended June 30 was $652 million, down from $667 million a year earlier. Analysts surveyed by Capital expected $682.4 million. The company said it...

ExxonMobil's Q2 Earnings: Permian Dominance Drives Production Growth, Plans $19B Buyback In FY24

Aug 2, 2024

Exxon Mobil Corporation ( XOM ) shares are trading lower after the company reported second-quarter FY24 results. Total revenues and other income stood at $93.060 billion, beating the consensus of $90.987 billion. Net production stood at 4,358 thousand oil-equivalent barrels per day, an increase of 15% from the previous quarter, driven by increased volumes from Pioneer, Guyana, and the heritage Permian assets. Adjusted net...